Jacob Borrajo
Chief Executive Officer at Amber Bio, Inc.
Jacob Borrajo active positions
Companies | Position | Start | End |
---|---|---|---|
Amber Bio, Inc.
Amber Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Amber Bio, Inc. is a biotechnology company based in an undisclosed location. The American company is focused on developing a first-of-its-kind RNA editing platform that can correct genetic mutations in a safe and reversible way. Amber Bio is pioneering new gene editing modalities using multi-kilobase RNA writing to reach previously undruggable diseases. Co-founders Jacob Borrajo and Basem Al-Shayeb received their Ph.D. at leading institutions for gene editing research: Broad Institute of MIT & Harvard and University of California. Jacob Borrajo has been the CEO since incorporation. | Chief Executive Officer | - | - |
Founder | - | - |
Career history of Jacob Borrajo
Former positions of Jacob Borrajo
Companies | Position | Start | End |
---|---|---|---|
Coral Genomics, Inc.
Coral Genomics, Inc. Pharmaceuticals: MajorHealth Technology Coral Genomics, Inc. operates as a biotechnology company that optimizes drug development and deployment by utilizing genomic data from patients. The company was founded by Jacob Borrajo and Atray Dixit in 2018 and is headquartered in San Francisco, CA. | Founder | 2017-12-31 | - |
Statistics
International
United States | 3 |
Operational
Founder | 2 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Coral Genomics, Inc.
Coral Genomics, Inc. Pharmaceuticals: MajorHealth Technology Coral Genomics, Inc. operates as a biotechnology company that optimizes drug development and deployment by utilizing genomic data from patients. The company was founded by Jacob Borrajo and Atray Dixit in 2018 and is headquartered in San Francisco, CA. | Health Technology |
Amber Bio, Inc.
Amber Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Amber Bio, Inc. is a biotechnology company based in an undisclosed location. The American company is focused on developing a first-of-its-kind RNA editing platform that can correct genetic mutations in a safe and reversible way. Amber Bio is pioneering new gene editing modalities using multi-kilobase RNA writing to reach previously undruggable diseases. Co-founders Jacob Borrajo and Basem Al-Shayeb received their Ph.D. at leading institutions for gene editing research: Broad Institute of MIT & Harvard and University of California. Jacob Borrajo has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Jacob Borrajo
- Experience